SYSNAV Healthcare developed a unique sensor technology to measure motion patterns, along with algorithms to transform real-world data into variables and endpoints. They represent patients’ comprehensive activity for upper and/or lower limbs in the context of clinical research or support for diagnosis, patient stratification, therapeutic efficacy monitoring, and medical indication claims.
« Lower limb » module:
This module can be used for instance in the stride monitoring, in cases of Duchenne muscular dystrophy (DMD). Research is on-going for several neuromuscular disease (SMA, FSHD) and neurological troubles disease (Angelman syndrome, SLA, …)
« Upper limb » module:
This module is useful in the monitoring of power and reach of movements, for instance in cases of SMA, myopathies or limb girdle dystrophy, or to check the coordination of movements in cases of ataxia.
« Movement disorder » module:
The module can be used in the monitoring of patients suffering from FSHD and Parkinson.
« On demand » module:
Tests for clinical trials or diagnosis should not be a burden on patients, their families or clinical teams. But patient motor function is complex, with short-term variability such as fatigue and long-term evolutions such as disease progression or the effects of treatment.
Syde enables precise, continuous evaluation of motor function in real life, limiting or eliminating shortcomings and bias associated with assessments done in clinics.
Syde has been designed and improved in partnership with healthcare professionals and patient associations in order to engineer features that meet their needs and to make wearing the sensors comfortable, whatever the patient’s lifestyle, which is crucial for reliable data.
Syde was designed so that technology fit the patient, not the other way round. Hassle-free, Syde is easy to use and you’ll quickly forget about it!
Thanks to the magneto-inertial technology, Syde is designed to withstand indoor and outdoor. With its nomad pack, Syde will record and store data all week long even without connexion. Data will be transferred & analyzed when the patient will connect the sensors to the docking station.
Syde’s sensors are small enough to remain invisible under trousers, discrete at wrists, light with its bracelet, designed for comfort, Syde likes to go unnoticed.
Technology progress can rhyme with esthetic and appealing design. Syde adapts to patient’s tastes whatever their age.
Syde sensors are waterproof to comply with patient lifestyle and robust enough so that the patient does not have to worry moving. They can withstand shocks, bumps of everyday life, so that patients don’t have to worry about restraining their movement in order to protect them during their activities.
Designing high precision equiment is in the DNA of Sysnav. Precision is #1 priority to collect highly trustworthy and meaningful data. Syde is now precise enough to be qualified by the EMA.
As digital technology becomes the norm in healthcare, Sysnav is taking a big commitment to keep patients' data secured & private. No location-tracking data are generated or collected, and security is at the center of the development of our devices & processes.
With the data collected thanks to the magneto inertial technology and different sensors, Syde provides high precision continuous real-life data collection to reconstruct 3D trajectory and offer a wide range of possibilities regarding clinical outcome assessments
Each Syde case contains ready-to-use elements to quickly start data collection:
Syde is a CE-marked medical device submitted to a conformity assessment to demonstrate that they meet legal requirements to ensure they are safe and perform as intended. SYSNAV Healthcare is also a proud member of the Digital Medicine Society, the first organization to gather experts from all disciplines to “advance the safe, effective, equitable, and ethical use of digital medicine to optimize human health”.
Apprentissage statistique pour l’actimétrie du piéton à partir de données inertielles : http://jds2017.sfds.asso.fr/program/Soumissions/subm157.pdf
New criteria for assessing the achievement of upper limbs in FSHD patients : https://www.nmd-journal.com/article/S0960-8966(16)30590-9/fulltext
Physiotherapy & ActiMyo:
FSHD with severe asymmetrical weakness of abdominal muscles:
87% of patients using ActiMyo tolerate it well or very well. Patients find the device easy to use and light,
and do feel more implicated and motivated to move while wearing it.
Additional applications for the Syde device include the evolution of patients with multiple sclerosis or parkinson diseases. SYSNAV Healthcare provides clinical studies with more sensitive and reliable outcome measures that we miss today.
Professor of pediatric neuromuscular diseases at the MDUK Oxford Neuromuscular Centre
Covid-19 pandemic experience has disrupted the course of several clinical trials and illustrated the interest of collecting data in a real-life setting
SV95C represents the spontaneous maximal velocity of patients at home and thus an image of patients real-life top performances